NCT03169803
Cardiac Output Autonomic Stimulation Therapy for Acute Heart Failure (COAST-AHF)
Cardiac Output Autonomic Stimulation Therapy for Acute Heart Failure (COAST-AHF) - System Design Study
NeuroTronik Inc.·ClinicalTrials.gov·device·Device trial
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Heart Failure Acute
- Drug/Device/Intervention
- NeuroTronik CANS Therapy™ System
- Study type
- Interventional
- Intervention type
- device
Sponsor & location
- Primary sponsor
- NeuroTronik Inc.
- Location
- Panama City, Panama
Timeline & enrollment
- Phase
- N/A
- Start date
- May 19, 2017
- End date
- Jun 19, 2019
- Enrollment
- 40 participants
Primary outcome
Arterial blood pressure,Heart Rate
Summary
A feasibility study to investigate the safety and performance of the NeuroTronik Cardiac
 Autonomic Nerve Stimulation (CANS) Therapy System
ICD-10 classifications
Heart failureHeart failure, unspecifiedCongestive heart failureInjury of heartInjury of heart, unspecified
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT03169803
- Type
- Device Trial
About this record
Access comprehensive clinical trial information for NCT03169803 through Pure Global AI's free database. This phase not specified trial is sponsored by NeuroTronik Inc. and is currently status unknown. The study focuses on Heart Failure Acute. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.